首頁 > 市場調查報告書 > 材料

市場調查報告書

商品編碼

1575783

全球 II 型膠原蛋白市場 - 2024-2031

Global Type II Collagen Market - 2024-2031

出版日期: 2024年10月22日 | 出版商:

DataM Intelligence | 英文 202 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

報告概述

2023年，全球II型膠原蛋白市場規模達2.1448億美元，預計2031年將達到3.0292億美元，2024-2031年預測期間複合年成長率為4.41%。

隨著全球人口老化的成長，人們對關節健康和行動能力問題的認知不斷增強。 II 型膠原蛋白以其支持軟骨和關節功能的能力而聞名，其需求量正在增加。這一趨勢推動了全球 II 型膠原蛋白市場的擴張，尤其是老年消費者和生活方式積極、重視關節健康的個人。

世界衛生組織表示，各國在為衛生和社會系統做好準備以應對人口迅速老化方面面臨重大挑戰。到2050年，預計80%的老年人將居住在低收入和中等收入國家，人口老化速度正以前所未有的速度加快。

2020年，60歲及以上的人口數量首次超過5歲以下兒童的數量。此外，2015年至2050年間，全球60歲以上人口比例將增加近一倍，從12%增加至22%。這種人口變化需要採取緊急行動，使醫療保健和社會支持系統適應老年人的需求。

市場動態

骨關節炎盛行率上升

隨著骨關節炎變得越來越普遍，特別是在老齡化人口中，對有效治療和關節保健補充劑的需求顯著增加。 II 型膠原蛋白以其支持關節健康和減少發炎的作用而聞名，擴大被納入膳食補充劑、功能性食品和藥物中，以滿足受這種疾病影響的人們日益成長的需求。

例如，根據骨關節炎 (OA) 行動聯盟的數據，骨關節炎的盛行率因年齡、性別和種族而異。從年齡來看，43% 的 OA 患者年齡在 65 歲或以上，88% 的患者年齡在 45 歲或以上。膝關節 OA 的年發病率最高發生在 55 歲至 64 歲之間，儘管有症狀的膝關節 OA 患者中一半以上年齡在 65 歲以下。雖然 OA 在 45 歲以下的男性中更為常見，但在該年齡之後的女性中也更為常見。就種族而言，78% 的 OA 患者是非西班牙裔白人。

人們對運動營養的興趣日益濃厚

人們對運動營養日益成長的興趣預計將顯著推動全球 II 型膠原蛋白市場。隨著運動員和健身愛好者越來越關注關節健康、恢復和性能增強，II 型膠原蛋白因其在支持關節完整性、減少發炎和促進軟骨修復方面的潛在益處而受到關注，從而推動市場成長。

市場對膠原蛋白補充劑的需求不斷成長，尤其是從事高強度運動的個人。這些消費者尋求有助於維持關節健康和預防受傷的產品，從而有助於擴大 II 型膠原蛋白在更廣泛的運動營養市場中的佔有率。人們越來越認知到膠原蛋白在改善活動性和靈活性方面的作用，進一步支持了這一趨勢，使其成為運動補充劑和功能性食品市場的關鍵成分。

Bulk 執行長表示，肌力訓練的日益普及推動了直接面對消費者(DTC) 的營養品牌取得了破紀錄的業績，2023 年收入猛增30%，達到1.231 億歐元。紀錄的業績新客戶的大量獲取是這一成長背後的關鍵驅動力。 Bulk 去年增加了近 80 萬名新客戶，銷售了超過 900 萬種產品，其中透明乳清蛋白成為成長最快的產品線，而價值必需品系列在生活成本危機中表現良好。

肌酸產品在注重肌肉量增強的客戶中仍然很受歡迎，而膠原蛋白和鎂產品作為恢復解決方案的需求不斷增加。儘管通貨膨脹導致原料成本上漲，Bulk 令人印象深刻的收入將調整後的 EBITDA 從 2022 年的 260 萬歐元增至 930 萬歐元，稅前利潤從上一年的 66,000 歐元增加到 600 萬歐元。

素食和道德問題

隨著消費者需求轉向植物性和零殘忍產品，越來越多的市場對動物來源的產品越來越警惕，例如通常源自雞胸骨或其他動物組織的 II 型膠原蛋白。這種道德立場，加上全球素食人口的不斷增加，可能會阻礙 II 型膠原蛋白市場的成長，因為消費者正在尋求替代的、基於植物的關節健康和皮膚護理解決方案。

此外，隨著品牌圍繞動物福利和永續性展開道德辯論，II 型膠原蛋白市場也可能面臨挑戰。動物性膠原蛋白的生產方法經常受到環境影響的審查，這可能會進一步抑制永續性和道德採購高度優先的市場的需求，從而限制市場成長。

細分市場分析

全球 II 型膠原蛋白市場根據形式、來源、應用和地區進行細分。

消費者對 II 型膠原蛋白皮膚保健品的需求不斷成長

由於消費者對皮膚保健產品的需求不斷成長，以及人們越來越認知到膠原蛋白在增強皮膚彈性、水合作用和整體外觀方面的作用，化妝品領域在全球 II 型膠原蛋白市場中佔有最大佔有率。隨著消費者越來越注重保持年輕容顏，抗衰老產品越來越受歡迎，其中 II 型膠原蛋白成為關鍵成分。

對抗衰老和嫩膚解決方案不斷成長的需求正在推動化妝品市場的發展，而 II 型膠原蛋白已被證實具有功效。化妝品產業不斷發展創新產品形式，例如注入膠原蛋白的面膜、乳液和可攝取的美容補充劑。例如，2023 年 1 月 24 日，Geltor 推出 NuColl，進軍護髮市場，這是一種透過發酵生產的純素膠原蛋白。

市場地域佔有率

北美關節疾病的盛行率不斷增加

預計北美將主導全球 II 型膠原蛋白市場。主要促進因素是該地區人口迅速老化，這導致骨關節炎等關節疾病的盛行率不斷增加。這對關節保健補充劑產生了巨大的需求，其中 II 型膠原蛋白因其支持軟骨和改善關節功能的潛力而被廣泛使用。

在廣泛的行銷努力和強大的分銷管道的推動下，消費者對膠原蛋白補充劑的益處的認知不斷提高，這有助於北美市場的擴張。該地區還受益於高度發展的醫療保健基礎設施和強大的膳食補充劑市場，使人們更容易獲得膠原蛋白產品。這些趨勢，加上對產品創新和新配方的關注，正在幫助北美保持在全球 II 型膠原蛋白市場的領先地位。

市場競爭格局

該市場的主要全球參與者包括 Ashland Inc.、Athos Collagen Private Limited、Chondrex, Inc.、Advanced BioMatrix、Rousselot、Takara Bio Inc.、SouthernBiotech、REPROCELL Inc.、KOKEN CO., LTD。和金博生物製藥股份有限公司。

俄烏戰爭影響分析

持續不斷的俄羅斯-烏克蘭戰爭嚴重影響了全球 II 型膠原蛋白市場，影響了供應鏈和消費者行為。衝突擾亂了東歐的農業活動和貿易路線，導致該地區主要原料的短缺和價格上漲。供應鏈的中斷導致 II 型膠原蛋白市場製造商的生產成本增加，促使一些公司將這些成本轉嫁給消費者。

戰爭導致了更廣泛的經濟不穩定，影響了消費者的支出模式和優先事項。在不確定的時期，消費者可能會減少在補充劑上的可自由支配支出，包括 II 型膠原蛋白產品。隨著需求波動，這可能會減緩市場成長，特別是在嚴重依賴受影響國家進口的地區。

按形式

乾燥

液體

按來源

牛科

豬

家禽

其他

按申請

食品和飲料

衛生保健

化妝品

其他

按地區

北美洲

我們

加拿大

墨西哥

歐洲

德國

英國

法國

義大利

西班牙

歐洲其他地區

南美洲

巴西

阿根廷

南美洲其他地區

亞太

中國

印度

日本

澳洲

亞太其他地區

中東和非洲

主要進展

2023 年 11 月 4 日，總部位於海得拉巴的製藥公司 Lee Pharma 獲得行銷授權，在阿拉伯聯合大公國推出其 Bio-Cartilage SmoothWalk 片劑。這一里程碑標誌著該公司取得的重大成就，因為 Bio-Cartilage SmoothWalk 成為第一個在阿拉伯聯合大公國獲得許可的印度營養保健品。

2022年3月3日，中國領先的維生素和膳食補充品公司湯臣倍健在其Highflex關節健康品牌下推出了新的膠原蛋白產品。該產品含有 Collavant n2，這是一種來自 Bioiberica（巴塞隆納）的天然（未變性）II 型膠原蛋白成分，經臨床證明可以緩解膝蓋不適並改善關節功能。

2021 年 4 月 20 日，Lonza 宣布擴大其 UC-II 未變性膠原蛋白成分系列，推出由經過認證的有機膠原蛋白製成並經過非基因改造項目驗證的新補充劑。新型 UC-II 未變性 II 型膠原蛋白旨在透過提供消費者友善的每日一次劑量來解決這一問題，為有機關節健康市場的人們提供更方便的選擇。

為什麼購買報告？

根據形式、來源、應用和地區可視化全球 II 型膠原蛋白市場細分，並了解關鍵商業資產和參與者。

透過分析趨勢和共同開發來識別商業機會。

Excel 電子表格包含 II 型膠原蛋白市場的綜合資料集，涵蓋所有細分級別。

PDF 報告由詳盡的質性訪談和深入研究後的綜合分析組成。

產品映射以 Excel 形式提供，包含所有主要參與者的關鍵產品。

全球 II 型膠原蛋白市場報告將提供約 62 個表格、53 張圖表和 202 頁。

2024 年目標受眾

製造商/買家

產業投資者/投資銀行家

研究專業人員

新興公司

As the aging population grows globally, there is an increasing awareness of joint health and mobility issues. Type II collagen, known for its ability to support cartilage and joint function, is seeing heightened demand. The trend drives global type II collagen market expansion, particularly among elderly consumers and individuals with active lifestyles who prioritize joint health.

According to the World Health Organization, countries face significant challenges in preparing their health and social systems for the rapid demographic shift toward an aging population. By 2050, it is projected that 80% of older adults will reside in low- and middle-income countries and the pace of population aging is accelerating at an unprecedented rate.

In 2020, for the first time, the number of people aged 60 years and older surpassed the number of children under the age of five. Furthermore, between 2015 and 2050, the proportion of the global population over 60 will nearly double, increasing from 12% to 22%. This demographic change requires urgent action to adapt healthcare and social support systems to the needs of older individuals.

Market Dynamics

Rising Prevalence of Osteoarthritis

As osteoarthritis becomes more common, especially among the aging population, the demand for effective treatments and joint health supplements significantly increases. Type II collagen, known for its role in supporting joint health and reducing inflammation, is increasingly being incorporated into dietary supplements, functional foods and pharmaceuticals to address the growing needs of those affected by this condition.

For instance, according to the Osteoarthritis (OA) Action Alliance, the prevalence of OA varies by age, gender and ethnicity. Age-wise, 43% of individuals with OA are 65 or older and 88% are 45 or older. The highest annual incidence of knee OA occurs between the ages of 55 and 64, although more than half of those with symptomatic knee OA are under 65. Gender differences show that 62% of individuals with OA are women. While OA is more common in men under 45, it becomes more prevalent in women after that age. In terms of ethnicity, 78% of those with OA are non-Hispanic whites.

Growing Interest in Sports Nutrition

The growing interest in sports nutrition is expected to drive the global type II collagen market significantly. As athletes and fitness enthusiasts increasingly focus on joint health, recovery and performance enhancement, type II collagen is gaining attention for its potential benefits in supporting joint integrity, reducing inflammation and promoting cartilage repair, driving the market growth.

The market is witnessing a rise in demand for collagen-based supplements, especially from individuals engaged in high-impact sports. These consumers seek products that can help maintain their joint health and prevent injury, contributing to the expansion of the type II collagen segment within the broader sports nutrition market. This trend is further supported by the growing awareness of collagen's role in improving mobility and flexibility, making it a key ingredient in the market for sports supplements and functional foods.

According to Bulk CEO, the rising popularity of strength training has propelled the direct-to-consumer (DTC) nutrition brand to a record-breaking performance, with revenues surging by 30% to EUR 123.1 million in 2023. Strong customer retention and record-high new customer acquisition were key drivers behind this growth. Bulk added nearly 800,000 new customers last year and sold over nine million products, with clear whey protein emerging as the fastest-growing line and the value essentials range performing well amid the cost of living crisis.

Creatine products remained popular among customers focused on muscle mass building, while collagen and magnesium products saw increased demand as recovery solutions. Bulk's impressive revenues boosted adjusted EBITDA to EUR 9.3 million, up from EUR 2.6 million in 2022 and pre-tax profits rose to EUR 6 million, compared to just EUR 66k the previous year, despite inflation-driven ingredient cost hikes.

Vegan and Ethical Concerns

As consumer demand shifts towards plant-based and cruelty-free products, a growing segment of the market is becoming increasingly wary of products derived from animal sources, such as type II collagen, which is typically sourced from chicken sternum or other animal tissues. This ethical stance, combined with the rising vegan population globally, may hinder the growth of the type II collagen market, as consumers seek alternative, plant-based solutions for joint health and skin care.

Moreover, the type II collagen market is also likely to face challenges as brands navigate the ethical debates around animal welfare and sustainability. The production methods for animal-derived collagen are often scrutinized for their environmental impact, which can further dampen demand in markets where sustainability and ethical sourcing are high priorities, restraining market growth.

Market Segment Analysis

The global type II collagen market is segmented based on form, source, application and region.

Rising Consumer Demand for Type II Collagen Skin Health Products

The cosmetics segment holds the largest share of the global type II collagen market due to a combination of rising consumer demand for skin health products and the increasing awareness of collagen's role in enhancing skin elasticity, hydration and overall appearance. As consumers become more focused on maintaining a youthful appearance, there is a surge in the popularity of anti-aging products, with type II collagen becoming a key ingredient.

The growing demand for anti-aging and skin-rejuvenating solutions is driving the cosmetics market forward with type II collagen's proven benefits. The cosmetics industry is continually evolving with innovative product formats such as collagen-infused masks, lotions and ingestible beauty supplements. For instance, on January 24, 2023, Geltor expanded into the hair care market with the launch of NuColl, a vegan collagen produced through fermentation.

Market Geographical Share

Increasing Prevalence of Joint Disorders in North America

North America is expected to dominate the global type II collagen market. The primary driver is the region's rapidly aging population, which is leading to an increasing prevalence of joint disorders such as osteoarthritis. This is creating significant demand for joint health supplements, where type II collagen is widely used for its potential to support cartilage and improve joint function.

Growing consumer awareness about the benefits of collagen supplements, driven by extensive marketing efforts and strong distribution channels, is contributing to market expansion in North America. The region also benefits from a highly developed healthcare infrastructure and a robust dietary supplement market, allowing for easier access to collagen-based products. These trends, along with a focus on product innovation and new formulations, are helping North America maintain its leading position in the global type II collagen market.

Market Competitive Landscape

The major global players in the market include Ashland Inc., Athos Collagen Private Limited, Chondrex, Inc., Advanced BioMatrix, Rousselot, Takara Bio Inc., SouthernBiotech, REPROCELL Inc., KOKEN CO., LTD. and JINBO BIO-PHARMACEUTICAL CORPORATION LIMITED.

Russia-Ukraine War Impact Analysis

The ongoing Russia-Ukraine war has significantly affected the global type II collagen market, influencing supply chains and consumer behavior. The conflict has disrupted agricultural activities and trade routes in Eastern Europe, leading to shortages and increased prices of key ingredients sourced from the region. This disruption in supply chains has resulted in heightened production costs for manufacturers in the type II collagen market, prompting some companies to pass these costs on to consumers.

The war has contributed to broader economic instability, affecting consumer spending patterns and priorities. In times of uncertainty, consumers may reduce discretionary spending on supplements, including type II collagen products. This could slow market growth as demand fluctuates, especially in regions heavily reliant on imports from affected countries.

By Form

Dry

Liquid

By Source

Bovine

Porcine

Poultry

Others

By Application

Food and beverage

Healthcare

Cosmetics

Others

By Region

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

On November 4, 2023, Lee Pharma, a Hyderabad-based pharmaceutical company, received marketing authorization to launch its Bio-Cartilage SmoothWalk tablets in the United Arab Emirates. This milestone marks a significant achievement for the company, as Bio-Cartilage SmoothWalk becomes the first Indian nutraceutical product to be licensed in the UAE.

On March 3, 2022, ByHealth, a leading vitamin and dietary supplements company in China, introduced a new collagen product under its Highflex joint health brand. This product features Collavant n2, a native (undenatured) type II collagen ingredient from Bioiberica (Barcelona), which has been clinically proven to alleviate knee discomfort and improve joint function.

On April 20, 2021, Lonza announced the expansion of its UC-II undenatured collagen ingredient line with the launch of a new supplement made from certified organic collagen and verified by the Non-GMO Project. The new UC-II undenatured type II collagen aims to solve this by offering a consumer-friendly, once-daily dose, providing a more convenient option for those in the organic joint-health market.

Why Purchase the Report?

To visualize the global type II collagen market segmentation based on form, source, application and region, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel spreadsheet containing a comprehensive dataset of the type-ii-collagen-market, covering all levels of segmentation.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The global type II collagen market report would provide approximately 62 tables, 53 figures and 202 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Form
3.2. Snippet by Source
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Prevalence of Osteoarthritis
  - 4.1.1.2. Growing Interest in Sports Nutrition
- 4.1.2. Restraints
  - 4.1.2.1. Vegan and Ethical Concerns
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. By Form

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 6.1.2. Market Attractiveness Index, By Form
6.2. Dry*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Liquid

7. By Source

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 7.1.2. Market Attractiveness Index, By Source
7.2. Bovine*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Porcine
7.4. Poultry
7.5. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Food and beverage*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Healthcare
8.4. Cosmetics
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. US
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. Australia
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Source
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Ashland Inc.*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Athos Collagen Private Limited
11.3. Chondrex, Inc.
11.4. Advanced BioMatrix
11.5. Rousselot
11.6. Takara Bio Inc.
11.7. SouthernBiotech
11.8. REPROCELL Inc.
11.9. KOKEN CO., LTD.
11.10. JINBO BIO-PHARMACEUTICAL CORPORATION LIMITED (*LIST NOT EXHAUSTIVE)